Navigation Links
GeneLink Reports First Quarter Gains
Date:5/11/2010

ORLANDO, Fla., May 11 /PRNewswire-FirstCall/ -- GeneLink, Inc. (OTC Bulletin Board: GNLK), a leading consumer genomics biotech company, today reported financial results for the fiscal quarter ended March 31, 2010.

Financial Highlights:

  • Continued progress towards profitability: Quarterly operating loss reduced by 14% over Q4 2009
  • Comparable quarter gross profit improvement over Q1 2009 of 37%
  • Q1 Revenues of  $2,221,111, a 12.6% increase over Q1 2009

Gary Beeman, GeneLink's CEO stated, "The first quarter of 2010 continues to reflect the positive impact of the steps initiated in late 2009 to increase our profit margins as GeneLink continued to make progress towards profitability in 2010, with operating losses dropping 14% as compared to the prior quarter.  In addition to continuing our investment in growing and improving the financial performance of our existing GeneWize sales operations, we are focusing on expanding the revenue base at GeneLink in market areas that we previously could not reach."  

Dr. Bernard Kasten, GeneLink's Executive Chairman added, "The first quarter was notable not only for the continued reduction of losses, but more so for the addition of Gary Beeman as CEO.  Gary has already helped GeneLink expand its vision and aspirations in ways which will start to evidence themselves in the coming months in our product offerings, business partnerships, and financial performance."

About GeneLink Biosciences, Inc.:

GeneLink is a 16-year old leading bioscienc
'/>"/>

SOURCE GeneLink, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
2. Winner Medical Reports Second Quarter Results for the Fiscal Year 2010
3. China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results
4. BMP Sunstone Reports First Quarter 2010 Financial Results
5. American Oriental Bioengineering Reports First Quarter 2010 Financial Results
6. OncoGenex Reports First Quarter Financial Results
7. Oncothyreon reports full year and fourth quarter 2009 financial results
8. Oncothyreon reports first quarter 2010 financial results
9. Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients
10. Epeius Biotechnologies Reports Major Clinical Advances: Noteworthy Clinical Case Studies in Cancer Gene Therapy
11. Anavex reports animal study results as lead Alzheimers compound approaches phase 1 clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... MONMOUTH JUNCTION, N.J., March 31, 2015 ... immunotherapy company using blood purification to treat critically-ill ... provides an operational summary and reports financial results ... 2014 CytoSorb® product revenues were ... 281%, compared to 2013 CytoSorb® revenues of $0.8M ...
(Date:3/31/2015)... VANCOUVER , March 31, 2015  /PRNewswire/ ... announced today that it has filed with the Food ... New Drug ("IND") application related to the Company,s proposed ... of the IND application is required in order for ... US.  The IND application is a ...
(Date:3/31/2015)... OXFORD, England , March 31, 2015 ... Singapore ,   June 30 2015   ... technical and medical information products and services and publishing home ... Science Council has launched the Materials in ... be presented during the 8 th International Conference ...
(Date:3/31/2015)... FRANCISCO , March 31, 2015  Sonoa Health, ... Australia , has developed a world-first consumer health ... records, medication prescriptions, wearable devices and more. ... Stewart as its CEO, who brings to the ... corporate advisory, which has included working closely with the ...
Breaking Biology Technology:CytoSorbents Reports Record 2014 Revenue 2CytoSorbents Reports Record 2014 Revenue 3CytoSorbents Reports Record 2014 Revenue 4CytoSorbents Reports Record 2014 Revenue 5CytoSorbents Reports Record 2014 Revenue 6CytoSorbents Reports Record 2014 Revenue 7CytoSorbents Reports Record 2014 Revenue 8CytoSorbents Reports Record 2014 Revenue 9CytoSorbents Reports Record 2014 Revenue 10CytoSorbents Reports Record 2014 Revenue 11ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 3ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 4Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 2Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 3Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3
... Although Madison has made a deal with Georgia-based Cellnet ... not be an overnight event. Certain areas will be initially ... Square expected to be approved by the City Council in ... of Madison has taken an active role in brokering Cellnets ...
... State of Wisconsin Investment Board , which manages the 10th ... that it has preliminary approval to put up to $50 million ... between Mason Wells Biomedical Fund II and Venture ... investments with both firms $45 split between the two in ...
... recent phase-one study at UW-Madisons Waisman Center shows a ... and other neurodegenerative disorders. Their treatment could enable brain ... the bodys movement, to recover from the damage caused ... naturally occurring protein in the brain called glial cell-derived ...
Cached Biology Technology:Madison wireless deal goes forward with Cellnet 2Stem cells produce anti-disease protein in brain experiment 2
(Date:3/12/2015)... 2015 The mascots of the Atlantic Coast ... of Wake Forest Baptist Medical Center. They stopped by ... ACC Men,s Basketball Tournament. Young patients enjoyed bonding with ... their autographs. Brenner Children,s Hospital is the ... only children,s hospital in northwest North Carolina ...
(Date:3/11/2015)... , Mar. 11, 2015 Research and Markets ... the "Access Control Market by Product, Application & ... report to their offering. , This ... to reach $10.4 billion by 2020, with an estimated ... report covers the products types such as contact cards ...
(Date:3/10/2015)... , March 10, 2015 Transforming ... "Personalized Medicine in Human Space Flight" ... Thomas J. Goodwin , Ph.D. was recently featured by ... past two years. Specifically, "Personalized Medicine in ... scientific papers published in 2013 and 2014 from Springer ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... Ohio scientists hope to counter the re-emerging threat of ... a research report published in the June 2010 print issue ... ), scientists show how the protein CCL5 plays a protective ... disease in the early stages of infection. CCL5 is a ...
... California, San Diego have identified a previously unknown kinase that ... major role in the progression or metastasis of cancer cells. ... 31 online Early Edition of the Proceedings of the ... professor of pathology at the UCSD School of Medicine and ...
... There have been impressive advances in computational methods, allowing ... the atomic level. In its latest Perspectives in General ... (JGP) offers an in-depth look at several of these ... membrane proteins, with special focus on ion channels. The ...
Cached Biology News:Body's own proteins may lead the way in global fight against tuberculosis 2Newly discovered kinase regulates cytoskeleton, and perhaps holds key to how cancer cells spread 2
... The nature of proteomics demands the ... The superior performance of the AXIMA-CFRplus with ... than 5 ppm) provides increased confidence in ... blanking for enhanced sensitivity, automated sample target ...
QCPN...
... standard of the Axima range, the ... mass accuracy, resolution, sensitivity and mass ... both linear and reflectron time-of-flight analysis. ... enables the generation of seamless PSD, ...
... O-TOF creates a new category for MALDI. ... that has been licensed to the PerkinElmerSCIEX ... , As the first single MALDI-TOF mass ... cooling, the prOTOF 2000 represents a substantial ...
Biology Products: